WNK2 and neoplasm: When expressed on tumour cells CXCR3-A is pathogenic, interacting with CXCL-9 to promote tumour migration and invasion via the activation of phosphatidylinostol 3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways.